Navigation Links
The Leukemia & Lymphoma Society and Provid Pharmaceuticals Announce Collaboration on Treatment for Acute Myelogenous Leukemia
Date:6/10/2008

WHITE PLAINS, N.Y., June 10 /PRNewswire/ -- Provid Pharmaceuticals, Inc. and The Leukemia & Lymphoma Society (LLS) today jointly announced the execution of a research agreement to advance the development of a treatment for acute myelogenous leukemia.

Under the arrangement, LLS has contracted with Provid to supply expert medicinal chemistry services in support of an LLS-funded Specialized Center of Research (SCOR) grant at the University of Virginia under the direction of Prof. John Bushweller, Ph.D.

"Provid's expertise adds a critical component to our SCOR program that will help advance our efforts from 'interesting laboratory results' to potential therapies," said Dr. Bushweller.

Louis J. DeGennaro, Ph.D., Chief Scientific Officer of LLS, added, "Our partnership with Provid is the result of a detailed selection process to identify companies that have significant drug discovery experience and fills a critical need for medicinal chemistry expertise. We believe that working with Provid will advance our research programs and speed effective therapies to our patients."

"As a company that applies medicinal chemistry expertise to transform biological discoveries into valuable drug leads, we are enthusiastic to work closely with LLS and Dr. Bushweller in the field of blood cancers," said Dr. Gary Olson, Chief Executive Officer of Provid. "We will dedicate our experienced team to this project to accelerate the validation and translation of research results from the Bushweller lab into potential leads for drug development."

The Provid partnership marks the first project of the Academic Concierge Division announced under LLS's Therapy Acceleration Program (TAP). This innovative program is designed to leverage current academic research investments by providing investigators access to the same expertise and services that pharmaceutical companies utilize. The ultimate goal of all TAP contracts is to advance therapies for patients sufferi
'/>"/>

SOURCE The Leukemia & Lymphoma Society
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia
2. FDA Grants Orphan Drug Designation to TREANDA, an Investigational Treatment for Chronic Lymphocytic Leukemia
3. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA-based Diagnostics for Leukemia and Non Hodgkin Lymphoma
6. Center for Molecular Medicine Selected to Provide DNA Analysis for Childrens Oncology Group Leukemia Study
7. CombiMatrix and Clarient Collaborate to Market, Sell Novel Genomics-Based Test for Chronic Lymphotic Leukemia (CLL)
8. Cephalon Receives FDA Approval for TREANDA, a Novel Chemotherapy for Chronic Lymphocytic Leukemia
9. Genta Submits NDA Amendment to FDA for Genasense as Treatment of Chronic Lymphocytic Leukemia
10. Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkins Lymphoma
11. Aidas Rh-Apo2L Clinical Testing Shows Preliminary Efficacy in Helping to Treat Lung Cancer, Stomach Cancer, Lymphoma, Pancreatic Cancer & Kidney Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... 2015 , ... Knowledgent , the data and analytics firm, today announced ... data lakes in the healthcare industry. , As the Internet of Things (IoT) continues ... the last few years as more entities become technology enabled through Electronic Medical Records ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... infectious diseases has been discovered by researchers at the Keck Graduate Institute and ... previously untreatable diseases. , The findings were published online on August 27 by ...
(Date:9/1/2015)... Shire plc (LSE: SHP, NASDAQ: SHPG ) announces ... of Directors as a Non-Executive Director. Sara will also be ... the Shire Board. Both appointments will be effective as of ... President and Chief Executive Officer of Dun & Bradstreet, Inc. ... D&B, she helped drive the transformation of the company from ...
(Date:8/31/2015)... ... August 31, 2015 , ... In recent years, biodegradable plastics ... low carbon footprints and compostability. These properties can help in limiting the degradation ... basis of applications, the market for biodegradable plastics can be broadly segmented into ...
Breaking Biology Technology:New White Paper Explores Data Lake Opportunities in the Healthcare Industry 2Scientists Discover New Use for an Old Therapy Inhibiting Deadly Pathogens Including Ebola and Anthrax 2Scientists Discover New Use for an Old Therapy Inhibiting Deadly Pathogens Including Ebola and Anthrax 3Scientists Discover New Use for an Old Therapy Inhibiting Deadly Pathogens Including Ebola and Anthrax 4Shire Appoints Sara Mathew to Board of Directors 2Biodegradable Plastics Market Growing at 10.8% CAGR to 2020 2Biodegradable Plastics Market Growing at 10.8% CAGR to 2020 3Biodegradable Plastics Market Growing at 10.8% CAGR to 2020 4Biodegradable Plastics Market Growing at 10.8% CAGR to 2020 5
... REYKJAVIK, Iceland, April 3, 2008 U.S.,Preventive Medicine(R), ... Genetics, the global leader in gene discovery, today,announced ... add genetic testing to,expand both companies, personalized medicine ... of the letter of intent with deCODE is ...
... Research Results To Be Presented at Experimental Biology ... Wellmune WGP(R), a natural,immune-enhancing ingredient from Biothera, ... for study subjects to miss work or school ... the 2008 Experimental,Biology annual meeting., Don Cox, ...
... ,Pharmacyclics, Inc. (Nasdaq: PCYC ) today announced ... drug candidates at the,American Association for Cancer Research ... at the San Diego Convention Center in San ... histone deacetylase(HDAC),inhibitor, which is now in a multicenter ...
Cached Biology Technology:U.S. Preventive Medicine and deCODE Genetics Sign Letter of Intent to Expand Personalized Medicine Platform 2U.S. Preventive Medicine and deCODE Genetics Sign Letter of Intent to Expand Personalized Medicine Platform 3Wellmune WGP(R) Supplementation Alleviates Duration, Severity and 'Down Time' Due to Cold Symptoms 2Wellmune WGP(R) Supplementation Alleviates Duration, Severity and 'Down Time' Due to Cold Symptoms 3Pharmacyclics Announces Multiple Presentations at the American Association for Cancer Research Annual Meeting 2Pharmacyclics Announces Multiple Presentations at the American Association for Cancer Research Annual Meeting 3Pharmacyclics Announces Multiple Presentations at the American Association for Cancer Research Annual Meeting 4
(Date:8/31/2015)... -- Growing need for data security coupled ... to drive India biometrics market   ... " India Biometrics Market Forecast & Opportunities, 2020 ", biometrics ... grow at a CAGR of over 35% during 2015 - ... extensive use of biometric technology in the government sector. Ongoing ...
(Date:8/24/2015)... , August 24, 2015 The ... ,s largest biometrics manufacturer DERMALOG and its customized solutions ... "2015 African Biometrics Company of the Year Award". DERMALOG is ... Nigeria .   -Cross reference: Picture is ... - On Thursday evening, in ...
(Date:8/19/2015)... Aug. 19, 2015  VOXX International Corporation (Nasdaq: ... entered into a Definitive Agreement to purchase the ... authentication market leader EyeLock through an acquiring entity.  ... a controlling interest in the acquiring entity. The ... of due diligence.  Expanding on its existing supply ...
Breaking Biology News(10 mins):India Biometrics Market to Grow at Over 35% Through 2020, Says TechSci Research 2India Biometrics Market to Grow at Over 35% Through 2020, Says TechSci Research 3Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5
... researchers at Oregon State University, the world,s multi-billion dollar foundry ... that produces metal castings used in everything from water pumps ... thousands of years to before Greek and Roman times. It ... continues to evolve. Some modern technologies use various types ...
... Calif -- Nitrogen is a beneficial plant fertilizer in ... ecosystems, such as water pollution, acidification of soils, increased ... a decline of native plant diversity. Over the ... amount of plant-available nitrogen inputs from the atmosphere compared ...
... for Experimental Biology (FASEB) commends Air India for continuing ... company, FASEB expressed its appreciation for Air India,s perseverance ... groups to discontinue shipping laboratory animals. "Animals are crucial ... the world are dependent upon their safe and humane ...
Cached Biology News:Sweet new approach discovered to help produce metal casting parts, reduce toxicity 2Researchers to study impacts of pollutant nitrogen on plant species diversity 2
PlusOne EDTA, disodium salt, 100 g. Category: Electrophoresis Systems & Standards & Reagents, Electrophoresis Standards and Reagents, Buffers....
...
Normal human serum collected off the clot from healthy normal humans. Each donor unit is negative for anti-HIV 1&2, HIV-Ag, HCV, and HBsAg by FDA required tests...
Normal human AB serum, pooled...
Biology Products: